Cirrus Resting State fMRI Software

by Sora Neuroscience  · Based in United States → — We strive to improve brain patient care using resting-state fMRI technology.
Neurology Neurosurgery Radiology

Regulatory Status Disclosed

Overview

Sora Neuroscience, Inc. is an emerging brain AI software company dedicated to providing clinically useful and rigorously tested resting-state functional MRI (fMRI) analysis tools. The company strives to improve brain patient care by leveraging resting-state fMRI technology developed and clinically investigated at Washington University in St. Louis (WashU) over the past decade.

Its flagship product, Cirrus Resting State fMRI Software, is an AI-based technology that rapidly maps the brain to locate sensitive areas controlling speech, vision, movement, and other critical functions.

Cirrus is designed for plug-and-play integration into existing imaging and neurosurgery platforms, with its output brain maps easily loaded onto a hospital’s surgical navigation platform of choice for seamless integration with existing surgical planning systems. The technology broadens the use of fMRI mapping to patient populations unable to perform task-based fMRI, including children and cognitively impaired patients, and offers a lower failure rate compared to traditional task fMRI.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-based brain mapping algorithms
  • Resting-state fMRI analysis
  • Rapid brain function mapping (as few as 12 minutes)
  • Identifies motor, language, and vision networks
  • Simplifies fMRI image acquisition
  • Automated post-processing
  • Plug-and-play integration with existing platforms
  • Output in DICOMu00ae format for surgical navigation systems
  • Expands fMRI access to patients unable to do task-based fMRI
  • Lower failure rate compared to task fMRI

Use Cases

  • Pre-surgical brain mapping for tumor resection
  • Pre-surgical brain mapping for epilepsy treatment
  • Enhancing precision in neurosurgical procedures
  • Treatment planning for neurological disorders
  • Targeting for repetitive transcranial magnetic stimulation (rTMS)
  • Functional localization for pediatric and cognitively impaired patients

What Physicians Need to Know

Brain MRI/CT Analysis
Cirrus processes individual patient brain MRI datasets, including BOLD fMRI and structural MRI data, to generate patient-specific motor, language, and vision resting-state fMRI correlation maps. It uses AI-based algorithms to analyze patterns of linked activity in a resting brain to identify areas of neurological activity. The software is designed to map critical functional networks and cerebrovascular reactivity in the brain.
Neurodegenerative Disease Screening
Cirrus maps can assist in planning treatment for brain disorders, including tumors, epilepsy, and other neurological conditions. The technology was developed to guide neurosurgeons in performing delicate brain surgeries to remove tumors or treat epilepsy.
Physician Tip

Cirrus Resting State fMRI Software provides automated resting-state fMRI analysis, generating DICOM RSN maps with a quality report for seamless integration into existing clinical and surgical planning systems. This allows for functional localization without patient participation, making it accessible for patients unable to perform traditional task-based fMRI workflows, including pediatric patients. The software can complete mapping of multiple brain networks from as few as 12 minutes of fMRI data. Cirrus maps are intended to be adjunctive and do not replace direct functional mapping procedures.

Cirrus is designed for seamless integration into existing clinical and surgical planning systems. It outputs brain maps in DICOM format, which can be easily imported into a hospital's surgical planning and navigation system of choice. Sora Neuroscience has a non-exclusive distribution partnership with Prism Clinical Imaging, making Cirrus available to users of Prism's brain mapping platform, which integrates fMRI, DTI, and other imaging tools.

Details

Category Neurology AI, Radiology & Imaging AI, Surgical AI
Pricing Unknown
DeploymentOn-premises to cloud-based
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Neurology, Neurosurgery, Radiology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2025-06-06K251009 510(k)Cirrus Resting State fMRI Software

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Cirrus Resting State fMRI Software

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Cirrus Resting State fMRI Software.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

Cirrus Resting State fMRI Software is an AI-based medical imaging software developed by Sora Neuroscience that processes resting-state fMRI data to create brain maps. These maps highlight motor, language, and vision networks, assisting neurosurgeons and radiologists in non-invasively visualizing functional brain areas for pre-surgical planning and clinical decision-making, particularly for procedures like tumor removal or epilepsy treatment.
Yes, Cirrus Resting State fMRI Software received FDA clearance on June 6, 2025. It is classified as Software as a Medical Device (SaMD) and is intended for prescription use by medical professionals. The software processes BOLD fMRI and structural MRI data using AI algorithms to generate patient-specific correlation maps in DICOM format.
While Cirrus offers significant advantages, its maps have been observed to vary in normal subjects during repeat MRI acquisitions, even when no functional mapping changes were expected. Additionally, the FDA labeling specifies that these resting-state maps are adjunctive and should not replace direct functional mapping procedures. The software's output is also limited to sensorimotor, language, and vision networks.
Traditional task-based fMRI is a common alternative, though it often requires patient participation and can be less reliable due to patient movement or inability to perform tasks. Other software platforms for fMRI processing and analysis include open-source options like FSL, AFNI, and SPM, as well as commercial suites like BrainVoyager. Major MRI manufacturers also offer integrated software for clinical fMRI.
Cirrus Resting State fMRI Software offers several advantages over traditional task-based fMRI. It can generate brain maps from as little as 12 minutes of resting-state fMRI data, making it quicker and more accessible for patients who cannot participate in task-based scans, such as children or those with cognitive impairments. Unlike task-based fMRI, which yields usable maps approximately two-thirds of the time, Cirrus scans can be reliably incorporated into surgical plans 87% of the time.
Pricing information for Sora Neuroscience's Cirrus Resting State fMRI Software is not publicly available. The company has a non-exclusive distribution relationship with Prism Clinical Imaging, Inc., to make Cirrus available to users of Prism's brain mapping platform.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-14 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.